Global Specialty Chemicals Leader Chooses Kneat for Digital Validation 
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021
Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash…
Biogen Announces Topline Results From Phase 2 Study of Gosuranemab, an Anti-Tau Antibody, for Alzheimer’s Disease
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced topline results…
NexImmune to Present at the Raymond James 2021 Human Health Innovation Conference
GAITHERSBURG, Md., June 16, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
Dr. Slavin Brings Deep Clinical, Academic and Industry Experience to New Role SALT LAKE CITY,…
Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
– All three dose strengths of STS101, administered with improved 2nd-generation nasal delivery device were…
Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease
More than 30 million Americans at risk for Lyme disease exposure, which can result in…
Collegium Announces Publication of Real-World Data in Journal of Pain Research
STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical…
Evelo Biosciences Announces Grant of Inducement Award
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical…
Novan Announces Proposed Public Offering of Common Stock
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (the “Company” or “Novan”) (NASDAQ:…
On substantial participation
JSC Olainfarm has received announcements on substantial participation from Anna Emīlija Maligina, SIA “OLMAFARM” and SIA…
Better Choice Announces Offering of Common Stock Concurrent With Uplisting to the NYSE American Stock Exchange
NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”),…
Kane Biotech launches 2021 business update series
Premiere episode “The Fundamentals” available now WINNIPEG, Manitoba, June 16, 2021 (GLOBE NEWSWIRE) — Kane…
LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) — LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a…
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference
WOBURN, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Mustang Bio to Present at the Raymond James Human Health Innovation Conference
WORCESTER, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Crinetics Pharmaceuticals Appoints Garlan Adams as General Counsel
SAN DIEGO, June 16, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical…
Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions
Company announcement – No. 39/2021 Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at…
KBP Biosciences Announces A Greater Than 10 mm Hg Systolic Blood Pressure Reduction in The BLOCK-CKD Phase 2b Study of KBP-5074 in Advanced Chronic Kidney Disease Patients with Uncontrolled Hypertension as Published in Hypertension
KBP-5074, a highly-selective non-steroidal mineralocorticoid receptor antagonist, lowered clinic systolic blood pressure (SBP) by 10.2…
VistaGen Therapeutics Set to Join the Russell 2000® Index
SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…